METROPOLITAN LIFE INSURANCE CO/NY - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$13,369
-29.0%
15,1920.0%0.00%0.0%
Q1 2022$18,838
-85.0%
15,192
-76.4%
0.00%
-50.0%
Q4 2021$125,553
-28.8%
64,3860.0%0.00%
-33.3%
Q3 2021$176,418
-13.0%
64,3860.0%0.00%0.0%
Q2 2021$202,81664,3860.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders